alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
II

106TH CONGRESS

1ST SESSION S. 1631

To provide for the payment of the graduate medical education of certain

interns and residents under title XVIII of the Social Security Act.

IN THE SENATE OF THE UNITED STATES

SEPTEMBER 23 (legislative day, SEPTEMBER 22), 1999

Mr. CONRAD introduced the following bill; which was read twice and referred

to the Committee on Finance

A BILL

To provide for the payment of the graduate medical education of certain interns and residents under title XVIII

of the Social Security Act.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Graduate Medical Edu5 cation Fair Technical Amendment Act of 1999’’.

6 SEC. 2. GME PAYMENTS FOR CERTAIN INTERNS AND RESI7 DENTS.

8 (a) INDIRECT AND DIRECT MEDICAL EDUCATION.—

9 Each limitation regarding the number of residents or in10 terns for which payment may be made under section 1886
2

•S 1631 IS

1 of the Social Security Act (42 U.S.C. 1395ww) is in2 creased by the number of applicable residents (as defined

3 in subsection (b)).

4 (b) APPLICABLE RESIDENT DEFINED.—For pur5 poses of this section, the term ‘‘applicable resident’’ means

6 a resident or intern that—

7 (1) participated in graduate medical education

8 at a facility of the Department of Veterans Affairs;

9 (2) was subsequently transferred on or after

10 January 1, 1997, and before July 31, 1998, to a

11 hospital and the hospital was not a Department of

12 Veterans Affairs facility; and

13 (3) was transferred because the approved med14 ical residency program in which the resident or in15 tern participated would lose accreditation by the Ac16 creditation Council on Graduate Medical Education

17 if such program continued to train residents at the

18 Department of Veterans Affairs facility.

19 (c) EFFECTIVE DATE.—

20 (1) IN GENERAL.—This section shall take effect

21 as if included in the enactment of the Balanced

22 Budget Act of 1997 (Public Law 105–33; 111 Stat.

23 251).

24 (2) RETROACTIVE PAYMENTS.—If the Secretary

25 of Health and Human Services determines that a
3

•S 1631 IS

1 hospital operating an approved medical residency

2 program is owed payments as a result of enactment

3 of this section, the Secretary shall make such pay4 ments not later than 60 days after the date of enact5 ment of this section.

Æ
Exhibit 23.1

CONSENT OF INDEPENDENT AUDITORS

The
Board of Directors and Stockholders
Vicinity Corporation:

We
consent to incorporation by reference in the registration statements (Nos. 333-83526, 333-96443, 333-96445, 333-30270, 333-55216,
333-56276 and 333-56278) on Form S-8 of Vicinity Corporation of our report dated July 19, 2002, except as to Note 17, which is as of
August 9, 2002, relating to the consolidated balance sheets of Vicinity Corporation and subsidiaries as of June 30, 2002 and July 31, 2001, and the related consolidated statements
of operations, stockholders' equity (deficit), and cash flows for the eleven months ended June 30, 2002 and the years ended July 31, 2001 and 2000, and the related financial statement
schedule, which report appears in the June 30, 2002, annual report on Form 10-K of Vicinity Corporation.

| |  | /s/KPMG LLP
| |  | -----------

Mountain
View, California
September 24, 2002

---

QuickLinks
**Exhibit
      32.1**





CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      SECTION 1350


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002





The
      undersigned, Colin Halpern, Chief Executive Officer, Acting Chief Financial
      Officer and Director of Universal Services Group, Inc. (the "Company"),
      certifies, under the standards set forth and solely for the purposes of 18
      U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
      2002, that, to his knowledge, the quarterly report on Form 10-QSB of the Company
      for the three month period ended February 1, 2003 fully complies with the
      requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
      and information contained in that Form 10-QSB fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.


Dated:
                August 15, 2007/s/
                Colin HalpernColin
                HalpernChief
                Executive Officer,Acting
              Chief
                Financial Officer and Director




A
      signed
      original of this written statement required by Section 906 has been provided
      to the Company and will be retained by the Company and furnished to the Securities
      and Exchange Commission or its staff upon request.
EXHIBIT 4.3.2



                                 AMENDMENT NO.1

                                       TO

                              AMENDED AND RESTATED
                         REGISTRATION RIGHTS AGREEMENT

      AMENDMENT NO. 1 to the Amended and Restated Registration Rights Agreement,
dated as of June 26, 1998 (the "Amendment"), by and among United Surgical
Partners International, Inc., a Delaware corporation (the "Company") and the
parties named at the foot hereof (each of such parties being hereinafter
referred to individually as a "Purchaser" and collectively as the "Purchasers"),
amending the Amended and Restated Registration Rights Agreement dated as of
April 30, 1998 among the Company and the several signatories thereto (the
"Registration Rights Agreement").

      On the date hereof, the Company and the Purchasers are consummating the
transactions contemplated by the Securities Purchase Agreement dated as of the
date hereof (the "Securities Purchase Agreement") pursuant to which the Company
has agreed to sell to the Purchasers an aggregate 400,000 shares of the
Company's Class A Common Stock, $.01 par value ("Class A Common Stock") (such
shares of Class A Common Stock being hereinafter collectively called the
"Shares").

      It is a condition to the closing of the transactions contemplated by the
Securities Purchase Agreement that the Company and the Purchasers execute this
Amendment.

      Pursuant to Section 13(d) of the Registration Rights Agreement, the
Registration Rights Agreement is hereby amended as follows:

      1. Each Purchaser is hereby made a party to the Registration Rights
Agreement with the same rights and obligations as a holder of "Investor Shares"
(with respect to the Shares) as set forth in the Registration Rights Agreement.

      2. The Registration Rights Agreement, as amended by this Amendment, is
hereby in all respects confirmed.

      3. This Amendment shall be governed by and construed in accordance with
the laws of the State of Delaware.
<PAGE>
      4. This Amendment may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute
one and the same instrument.



                               UNITED SURGICAL PARTNERS
                               INTERNATIONAL, INC.




                               By /s/ DONALD STEEN
                                      Donald Steen
                                      Chief Executive
EXHIBIT 23.1





CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM





We consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-187405) and Form S-8 (Nos. 333-42945, 333-42668, 333-96697, 333-127381, 333-130180, 333-136398, 333-143090, 333-149440, 333-150839, 333-176200, 333-183158, 333-183159 and 333-207341) of St. Jude Medical, Inc. of our report dated February 23, 2016 (except for Notes 1 and 9, as to which the date is June 7, 2016), with respect to the consolidated financial statements and schedule of St. Jude Medical, Inc., and the effectiveness of internal control over financial reporting of St. Jude Medical, Inc., included in this Current Report on Form 8-K.








/s/  Ernst & Young LLP


Minneapolis, Minnesota


June 7, 2016
EXHIBIT 31.2: Rule 13a-14(a) Certifications

 

I, Brien Reidy, certify that:

 

1.  I have reviewed this quarterly report on Form 10-Qof Hamptons Extreme, Inc.; 

2.  Based on my knowledge, this report does notcontain any untrue statement of a material fact or omit to state a materialfact necessary to make the statements made, in light of the circumstances underwhich such statements were made, not misleading with respect to the periodcovered by this report;

3.   Based on my knowledge, the financial statements,and other financial information included in this report, fairly present in allmaterial respects the financial condition, results of operations and cash flowsof the small business issuer as of, and for, the periods presented in thisreport;

4.  The Small business issuer’s other certifyingofficers and I are responsible for establishing and maintaining disclosurecontrols and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14)for the small business issuer and have:

 a)    Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision,  to ensure thatmaterial information relating to the small business issuer, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this  report is being prepared;

b)  Evaluated theeffectiveness of the small business issuer’s disclosure controls and proceduresand presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and 

c)  Disclosed in this report any change in the small business issuer’s internalcontrols over financial reporting that occurred during the small businessissuer’s most recent fiscal quarter (the small business issuer’s second fiscalquarter in the case of an annual report) that has materially affected, or isreasonably likely to materially affect, the small business issuer’s internalcontrol over financial reporting; and

5.  The issuer’s other certifying officers and I havedisclosed, based on our most recent evaluation of internal controls overfinancial reporting, to the small business issuer’s auditors and the auditcommittee of the issuer’s board of directors (or persons performing theequivalent functions):

a)  All significant deficiencies and materialweaknesses in the design or operation of internal controls over financialreporting which are reasonably likely to adversely affect the small businessissuer’s ability to record, process, summarize and report financialinformation; and 

b)  Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in the small businessissuer’s internal controls over financial reporting.  

Date: August 13, 2009          /s/ Brien Reidy

                                                Brien Reidy,Chief Financial Officer
AMENDMENT NO. 1 TO
                              AMENDED AND RESTATED
                              EMPLOYMENT AGREEMENT
                              --------------------


         AMENDMENT dated as of December 21, 2000, by and between Polo Ralph
Lauren Corporation, a Delaware corporation (the "Corporation"), and F. Lance
Isham (the "Executive").

         WHEREAS, the Corporation and the Executive are parties to an employment
agreement effective as of November 10, 1998, (the "Employment Agreement"); and

         WHEREAS, the Corporation and the Executive wish to amend the Employment
Agreement effective as of the date hereof in order to provide for the
modification of a certain provision of the agreement relating to the vesting of
the Executive's restricted stock;

         NOW, THEREFORE, intending to be bound the parties hereby agree as
follows with effect from the date first above written.

         1.       Subsection 4(e) of the Employment Agreement is hereby amended
by replacing the second sentence of such subsection with the following:

                           "The restricted shares will vest with respect to one
                  quarter (1/4) of the aggregate number of restricted shares so
                  granted on each of the second, third, fourth and fifth
                  anniversaries of the date of this Agreement subject to the
                  Executive's continued employment through each vesting date."

         2.       The Employment Agreement remains in full force and effect and
unmodified except as herein provided.

         3.       This Agreement may be executed in one or more counterparts,
each of which shall be deemed to be an original but all of which together will
constitute one and the same instrument.

<PAGE>


         IN WITNESS WHEREOF, each of the undersigned has executed this Agreement
as of the date first written above


                              POLO RALPH LAUREN CORPORATION


                              By:  /s/  Roger Farah
                                   --------------------------------------------





                                   /s/  F. Lance Isham
                              -------------------------------------------------
                              Executive:  F. Lance Isham


                                                                               2
---

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS
ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the accompanying Quarterly Report On Form
10-Q of Resource Group Inc. for the Quarter Ended November 30, 2008, I, James P.
Geiskopf, President and Chief Executive Officer of Resource Group, Inc.hereby
certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief,
that:

|1. | Such Quarterly Report on Form 10-Q for the Period Ended
      August 31, 2008, fully complies with the requirements of Section 13(a) or
      15(d) of the Securities Exchange Act of 1934; and                                             
|-- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   |                                                                                                                                                                                                                                             
|2. | The information contained in such Quarterly Report on
      Form 10-Q for the Period Ended August 31, 2008, fairly presents, in all
      material respects, the financial condition and results of operations of
      Resource Group, Inc.

|By:    | /s/ James P. Geiskopf                
|------ | -------------------------------------
|       | James Geiskopf                       
|       | President and Chief Executive Officer
|       |                                      
|       |                                      
|Dated: | December 31, 2008                    

---
<PAGE>   1



                                                                    EXHIBIT 10.1


                                    EXHIBIT A

                            JOINT REPORTING AGREEMENT

         In consideration of the mutual covenants herein contained, each of the
parties hereto represents to and agrees with the other parties as follows:

         1. Such party acknowledges that it is required and eligible to file a
statement on Schedule 13G pertaining to the common stock of Kosan Biosciences
Incorporated to which this agreement is an exhibit, for the filing of the
information contained therein.

         2. Such party is responsible for timely filing of such statement and
any amendments thereto, and for the completeness and accuracy of the information
concerning such party contained therein; provided that no such party is
responsible for the completeness or accuracy of the information concerning the
other party making the filing, unless such party knows or has reason to believe
that such information is inaccurate.

         3. Such party agrees that such statement is filed by and on behalf of
each such party and that any amendment thereto will be filed on behalf of each
such party.

         This agreement may be executed in one or more counterparts, each of
which shall be deemed to be an original instrument, but all of such counterparts
taken together shall constitute but one agreement.

Dated: February 13, 2001

                                    AG-BIOTECH CAPITAL, LLC

                                    By: VIRIDIAN MANAGEMENT, LLC, its Manager

                                    By: /s/ Helene S. Cohen
                                        -------------------------------------
                                        Helene S. Cohen, President

                                    SAVIA, S.A. de C.V.

                                    By: /s/ Carlos Gerardo Mahaud
                                        -------------------------------------
                                        Name: Carlos Gerardo Mahaud
                                              -------------------------------
                                        Title: Attorney in Fact
                                               ------------------------------

                                    ALFONSO ROMO GARZA

                                    /s/ Alfonso Romo Garza
                                        -------------------------------------
715 P.2d 355

#### Robert JONES and Ellis Hamsley, Plaintiffs-Appellants, v. E G & G IDAHO, INC., a corporation, Defendant-Respondent.

No. 15831.

Supreme Court of Idaho.

Jan. 30, 1986.

ORDER

The Appellants having filed a PETITION FOR REVIEW on October 22, 1985 and a supporting LETTER BRIEF on November 6, 1985 of the Opinion of the Court of Appeals filed October 2, 1985, 109 Idaho 400, 707 P.2d 511; Therefore, good cause appearing,

IT IS HEREBY ORDERED that the Appellants’ PETITION FOR REVIEW be, and hereby is, GRANTED as to all issues presented on appeal.

IT IS FURTHER ORDERED that Respondent shall file a Brief in response to the Brief filed by Appellants in support of the PETITION FOR REVIEW within twenty-one (21) days from the date of this Order. Appellants shall file any Reply Brief within fourteen (14) days from the date of filing of Respondent’s Brief.

IT IS FURTHER ORDERED that the Court of Appeals Case No. 15831 is CLOSED and Supreme Court Case No. 16338 shall be used on all future filings in this proceeding.
**Exhibit 99.7**

 

**CONSENT OF INDEPENDENT ACCOUNTANTS**

 

We hereby consent to theinclusion in this Annual Report on Form 40-F of our audit report dated March 24,2009 (July 28, 2009 as to the effects of the restatement discussed in Note18), on the consolidated balance sheet of Minera Andes Inc. as at December 31,2008 and the consolidated statements of operations and comprehensive loss,shareholders’ equity and cash flows for the year ended December 31, 2008which is incorporated by reference in this Annual Report on Form 40-F ofthe Company for the fiscal year ended December 31, 2009.

 

Furthermore, we also consentto the incorporation by reference in the Registration Statements on Form S-8(No. 333-155807), Form S-8 (No. 333-34023), Form S-8 (No. 333-135634)and Form S-3 (No. 333-77663) of Minera Andes Inc., of our reportdated July 28, 2009 relating to the consolidated financial statements ofMinera Andes Inc., which is incorporated in this Form 40-F.

 

We were not engaged toaudit, review, or apply any procedures to the adjustments as described in Notes2(a) and 13(h) and accordingly, we do not express an opinion or anyother form of assurance about whether such adjustments are appropriate and havebeen properly applied. Such adjustments were audited by KPMG LLP.

 

*(signed)BDO Canada LLP*

 

**CharteredAccountants**

Vancouver, British Columbia

March 29, 2010

 

----
II

106TH CONGRESS

1ST SESSION S. 1635

To amend the Agricultural Market Transition Act to extend the term of

marketing assistance loans.

IN THE SENATE OF THE UNITED STATES

SEPTEMBER 24, 1999

Mr. GRAMS introduced the following bill; which was read twice and referred

to the Committee on Agriculture, Nutrition, and Forestry

A BILL

To amend the Agricultural Market Transition Act to extend

the term of marketing assistance loans.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. TERM OF MARKETING ASSISTANCE LOANS.

4 Section 133 of the Agricultural Market Transition

5 Act (7 U.S.C. 7233) is amended—

6 (1) in subsection (a), by striking ‘‘9 months’’

7 and inserting ‘‘3 years’’; and

8 (2) by striking subsection (c) and inserting the

9 following:
2

•S 1635 IS

1 ‘‘(c) EXTENSION.—The Secretary may extend the

2 term of a marketing assistance loan made to producers

3 on a farm for any loan commodity for 1 9-month period

4 if the Secretary determines that the extension would be

5 beneficial to the producers in marketing the loan com6 modity.’’.

Æ
[Federal Register Volume 75, Number 87 (Thursday, May 6, 2010)]
[Notices]
[Page 24972]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-10451]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Network Centric Operations Industry Consortium, 
Inc.

    Notice is hereby given that, on April 6, 2010, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Network Centric Operations 
Industry Consortium, Inc. (``NCOIC'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, Computer Sciences Corporation, Rockville, 
MD; MEDA Holdings SAS, Le Plessis, FRANCE; NJVC LLC, Vienna, VA; and 
Center for Netcentric Product Research, East Hartford, CT have been 
added as parties to this venture. Also, Innerwall, Inc., Colorado 
Springs, CO; John Hopkins University Applied Physics Laboratory, 
Laurel, MD; and INDRA Sistemas S.A., Madrid, SPAIN, have withdrawn as 
parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and NCOIC intends to file additional 
written notifications disclosing all changes in membership.
    On November 19, 2004, NCOIC filed its original notification 
pursuant to Section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to Section 6(b) of 
the Act on February 2, 2005 (70 FR 5486).
    The last notification was filed with the Department on January 11, 
2010. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on February 23, 2010 (75 FR 8116).

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 2010-10451 Filed 5-5-10; 8:45 am]
BILLING CODE 4410-11-M